Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin.
about
Lipids and Oxidative Stress Associated with Ethanol-Induced Neurological DamageThe Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and ProgressionModulation of hepatic lipid metabolism by olive oil and its phenols in nonalcoholic fatty liver diseaseLipids in the assembly of membrane proteins and organization of protein supercomplexes: implications for lipid-linked disordersALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosisOxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver diseaseChemoproteomic Profiling of Bile Acid Interacting ProteinsImpaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats.High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes.Role of choline deficiency in the Fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet.Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.The functions of cardiolipin in cellular metabolism-potential modifiers of the Barth syndrome phenotypeComparative metabolomic and genomic analyses of TCDD-elicited metabolic disruption in mouse and rat liverCholine and Cystine Deficient Diets in Animal Models with Hepatocellular Injury: Evaluation of Oxidative Stress and Expression of RAGE, TNF-α, and IL-1β.Coenzyme Q metabolism is disturbed in high fat diet-induced non-alcoholic fatty liver disease in ratsDietary choline deficiency causes DNA strand breaks and alters epigenetic marks on DNA and histones.Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression.Hedgehog signaling is a potent regulator of liver lipid metabolism and reveals a GLI-code associated with steatosis.Hepatic steatosis in overweight/obese females: new screening method for those at riskScreening for the drug-phospholipid interaction: correlation to phospholipidosis.Formation and regulation of mitochondrial membranes.Mitochondrial dysfunction in nonalcoholic steatohepatitis.Free radical oxidation of cardiolipin: chemical mechanisms, detection and implication in apoptosis, mitochondrial dysfunction and human diseases.Pathological alteration in the choroid plexus of Alzheimer's disease: implication for new therapy approachesImpact of high dietary lipid intake and related metabolic disorders on the abundance and acyl composition of the unique mitochondrial phospholipid, cardiolipin.Impaired Cardiolipin Biosynthesis Prevents Hepatic Steatosis and Diet-Induced Obesity.Lipidomic Evaluation of Aryl Hydrocarbon Receptor-Mediated Hepatic Steatosis in Male and Female Mice Elicited by 2,3,7,8-Tetrachlorodibenzo-p-dioxin.Altered distribution of caveolin-1 in early liver steatosis.Hepatoprotective effect of grape seed proanthocyanidins on Cadmium-induced hepatic injury in rats: Possible involvement of mitochondrial dysfunction, inflammation and apoptosisDeletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome.Biochemical mechanisms in drug-induced liver injury: certainties and doubts.Methylglyoxal induces oxidative stress and mitochondrial dysfunction in osteoblastic MC3T3-E1 cells.Interleukin-6 is associated with liver lipid homeostasis but not with cell death in experimental hepatic steatosis.Dietary fatty acids modulate liver mitochondrial cardiolipin content and its fatty acid composition in rats with non alcoholic fatty liver disease.Alcohol-induced oxidative/nitrosative stress alters brain mitochondrial membrane properties.Dietary choline deprivation impairs rat brain mitochondrial function and behavioral phenotype.Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q?Role of mitochondria and mitochondria targeted agents in non-alcoholic fatty liver disease.Comparison of dietary polyphenols for protection against molecular mechanisms underlying nonalcoholic fatty liver disease in a cell model of steatosis.Mitochondrial susceptibility in a model of paraquat neurotoxicity.
P2860
Q26767487-1A97AC5D-6F90-43E9-93F6-BDB2B7CEE9A5Q26775025-49FBED47-F539-4CF4-BDA0-A21618FC2B1BQ26827450-6F07A537-6BAF-4C86-BB67-166A8EC9A359Q28386214-2C161C41-4996-4949-A76C-0A73C429CD4CQ28386269-1BAD5418-6C86-4806-9DC0-15F4C30293A8Q28396128-F352C85F-340F-428F-9226-61942341CC03Q33731122-9565EFDC-E6A6-4E14-B28A-29D2378B4A8BQ33779364-90343460-457D-422C-AAB4-F7A685F48A96Q34212924-0A5E4F37-9C2B-48B2-9A7C-82C1AD2FF6B1Q34979884-D8CAF03E-FCBF-46F6-A818-F2E0D8C4321EQ35115065-8D240AAA-D735-42E0-87EB-CE455C9FF033Q35128445-DC076163-2430-4703-B68F-B5EB969625B7Q35626784-2E843CEF-9664-4097-8A4A-4B075090B69AQ35744933-17BEFCA3-095E-4E04-A1B7-A53ED44B9508Q35795775-5219463C-5F36-46F9-A88E-1B0A96BA2752Q35870744-EAFA776D-CE88-4481-B6CF-CEA12FDFEC7FQ36695961-5C35216D-D9A2-429F-BB02-A7A45EA11EE9Q36908863-07ED164A-BD60-4DA7-9657-C69F47DD4E0AQ37461182-7E6E3DE9-DE4B-41D8-90AE-C6E0ED737993Q37529605-1707D904-FEF3-4E2A-AA3E-D088DE4F66E9Q37571518-16EFC87A-B468-4F94-8802-6A1E24F15673Q37863137-54BB9896-857D-4A3E-A807-6F35E701DE6EQ37999099-67CA2587-DAFD-484B-85AD-8F6A7DF950B1Q38007947-1DD066B9-BBF0-48DE-8D63-BEB6EA5F1BF1Q38222116-EFE44F06-D190-47B4-A9F3-4028B513ACFFQ38408213-5119DECA-9119-41C0-BFF3-61774EE6F6CCQ38941605-359D1AA1-8E8C-44BA-B88E-65C3FCA6DEFFQ39791849-49EEDB7D-F391-40DA-A4D8-6E49D2131B32Q41679794-A8488811-C30F-4923-8FB7-18C15C8D6E9AQ41925566-3191A581-ABCA-430A-84D9-DDBDC151E25EQ42588200-7F6C9D7B-7B61-4704-BC7E-514482385B77Q42811134-62871AFD-38C3-43DA-A303-1912BE5F0876Q43285339-725ED75C-D157-4698-9CB3-40811511A55CQ43961291-E1EE939C-C4D2-405A-8421-B00E1F5692CDQ44476837-135BBA10-FE06-4729-AB4E-DC9AA0E5BB41Q45010837-077BFF42-C9EE-4A1C-8638-A90A46FF0AE9Q45927414-A33B66D3-8B7B-4EF4-A316-BF72B4C19C49Q46266754-E18848A4-1993-46C3-8903-6B0096CFDCF0Q46401825-F65CEF80-40F2-4D7A-99CC-A2D77FEB7D37Q46456255-C76E41FC-3C04-4E4B-B9EB-3BD0C66A5799
P2860
Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Mitochondrial dysfunction in r ...... xygen species and cardiolipin.
@ast
Mitochondrial dysfunction in r ...... xygen species and cardiolipin.
@en
Mitochondrial dysfunction in r ...... xygen species and cardiolipin.
@nl
type
label
Mitochondrial dysfunction in r ...... xygen species and cardiolipin.
@ast
Mitochondrial dysfunction in r ...... xygen species and cardiolipin.
@en
Mitochondrial dysfunction in r ...... xygen species and cardiolipin.
@nl
prefLabel
Mitochondrial dysfunction in r ...... xygen species and cardiolipin.
@ast
Mitochondrial dysfunction in r ...... xygen species and cardiolipin.
@en
Mitochondrial dysfunction in r ...... xygen species and cardiolipin.
@nl
P2093
P1476
Mitochondrial dysfunction in r ...... xygen species and cardiolipin.
@en
P2093
Domenico Ferri
Francesca M Ruggiero
Giacoma Casanova
Giuseppe Paradies
Giuseppe Petrosillo
Ignazio Grattagliano
Mariagiuseppa Matera
P304
P356
10.1016/J.BBABIO.2007.07.011
P407
P577
2007-08-25T00:00:00Z